HR 12

Introduction - 94th Legislature (2025 - 2026)

Posted on 05/11/2026 07:08 p.m.

A House resolution
designating May 3 to 9, 2026, as Tardive Dyskinesia Awareness Week.

WHEREAS, many people with serious mental health conditions, such as bipolar disorder,
major depression, schizophrenia, and schizoaffective disorder, or gastrointestinal disorders, including
gastroparesis, nausea, and vomiting, may be treated with medications that work as dopamine receptor
blocking agents (DRBAs), including antipsychotics; and

WHEREAS, while ongoing treatment with these medications can be necessary, prolonged
use can also lead to tardive dyskinesia (TD), an involuntary movement disorder that is characterized
by uncontrollable, abnormal, and repetitive movements of the face, torso, or other body parts; and

WHEREAS, it is estimated that TD affects approximately 800,000 people in the United
States, and approximately 60 percent of people with TD have not been diagnosed, making it important
to raise awareness about the symptoms and impact of TD because even mild symptoms of TD can
have physical, social, and emotional consequences; and

WHEREAS, it is essential that people taking DRBAs be monitored for TD, as regular
screening for TD in these patients is recommended by the American Psychiatric Association; and

WHEREAS, clinical research has led to the availability of two treatments for adults with TD
by the United States Food and Drug Administration; and

WHEREAS, the Minnesota State House of Representatives can raise awareness of tardive
dyskinesia in the public and medical community; NOW, THEREFORE,

BE IT RESOLVED by the House of Representatives of the State of Minnesota that it
designates May 3 to 9, 2026, as Tardive Dyskinesia Awareness Week and encourages each individual
in the state of Minnesota to become better informed about and aware of tardive dyskinesia.